Molecular Vision: Zhao, Mol Vis 2008; 14:1456-1464. Table 1

Table 1. Clinical features of patients with Behcet’s disease and the responsiveness of peripheral blood mononuclear cells against S-Ag peptides stimulation.

Patient number	Age (years)	Diagnosis	Special ocular manifestations	Extraocular symptoms	Response to S-Ag
1	35	active BD		, *	Positive
2	30	active BD	vitreous cells	, *	Positive
3	20	active BD	vitreous cells	, , **, ##	Positive
4	17	active BD	hypopyon, vitreous cells	, **, #	Positive
5	25	active BD	vitreous cells	, *	Positive
6	16	active BD	vitreous cells	, *	Positive
7	27	active BD	hypopyon, vitreous cells	, *	Positive
8	24	active BD	vitreous cells	, **, #	Positive
9	22	active BD		, *	Positive
10	29	active BD		, *	Positive
11	36	active BD		*, ##	Positive
12	44	active BD		, **	Positive
13	26	active BD		, *, ##	Positive
14	17	active BD	vitreous cells	, , **	Negative
15	40	active BD	hypopyon, vitreous cells	, , **, ##	Negative
16	33	active BD		, **	Negative
17	27	active BD		*, ##	Negative
18	24	active BD		*, #	Negative
19	25	active BD	vitreous cells	, *, #	Negative
20	19	active BD		, *	Negative
21	36	active BD	hypopyon, vitreous cells	, *	Negative
22	29	active BD		, , **	Negative
23	28	active BD		, *	Negative
24	42	inactive BD		, **, ##	Positive
25	29	inactive BD	hypopyon	, *	Positive
26	37	inactive BD		, *	Positive
27	41	inactive BD		, , **	Negative
28	34	inactive BD		, *, #, ##, ###	Negative
29	44	inactive BD	hypopyon	, , **, #, ##	Negative
30	39	inactive BD		, *	Negative
31	47	inactive BD		*, #	Negative
32	32	inactive BD	hypopyon	, , **, #	Negative
33	34	inactive BD		, **	Negative
34	34	inactive BD		, **	Negative
35	39	inactive BD		, , **, #, ###	Negative